A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data

Vaccine

Volumn 31, Issue S10, 2013, Pages

  Chung, Cecilia P ^a   Rohan, Patricia ^b   Krishnaswami, Shanthi ^c   McPheeters, Melissa L ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Administrative database; Algorithm; ICD 9; Positive predictive value; Rheumatoid arthritis; Validation

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

ALGORITHM; COMPUTER; CONTROLLED VOCABULARY; DATA BASE; DATA EXTRACTION; HUMAN; INFORMATION PROCESSING; INTERNATIONAL CLASSIFICATION OF DISEASES; PATIENT CARE; PHARMACY; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYSTEMATIC REVIEW; VALIDATION PROCESS;

A; ACR; ACUTE MYOCARDIAL INFARCTION; ADMINISTRATIVE DATABASE; ALGORITHM; AMERICAN COLLEGE OF RHEUMATOLOGY; AMI; ANA; ANTI-CCP; ANTI-CYCLIC CITRULLINATED PEPTIDE; ANTI-TNF; ANTI-TUMOR NECROSIS FACTOR; ANTINUCLEAR ANTIBODY; CD; CI; CONFIDENCE INTERVAL; CPT; CROHN'S DISEASE; CURRENT PROCEDURAL TERMINOLOGY; DATABASE; DB; DESERET MUTUAL BENEFITS ADMINISTRATION; DISEASE-MODIFYING ANTIRHEUMATIC DRUG; DMARD; DMBA; EDC; ELECTRONIC MEDICAL RECORDS; EMR; ESTIMATED DATE OF CONCEPTION; GEISINGER HEALTH SYSTEM; GHS; HCPCS; HEALTH CARE FINANCING ADMINISTRATION COMMON PROCEDURE CODING SYSTEM; HERPES ZOSTER; HZ; IBD; ICD; ICD-9; INFLAMMATORY BOWEL DISEASE; INTERNATIONAL CLASSIFICATION OF DISEASES; JRA; JUVENILE-ONSET RHEUMATOID ARTHRITIS; KAISER PERMANENTE NORTHERN CALIFORNIA; KPNC; MAINTENANCE ET EXPLOITATION DES DONNEES POUR L'ETUDE DE LA CLIENTELE HOSPITALIERE; MEDECHO; METHOTREXATE; MTX; NATIONAL DRUG CODE; NDC; NEGATIVE PREDICTIVE VALUE; NEW JERSEY; NJ; NMSC; NON-MELANOMA SKIN CANCER; NON-STEROIDAL ANTI-INFLAMMATORY DRUG; NPV; NSAID; OFFICE OF STATEWIDE HEALTH PLANNING AND DEVELOPMENT; OSHPD; PA; PACE; PENNSYLVANIA; PENNSYLVANIA ASSISTANCE CONTRACT FOR THE ELDERLY; POSITIVE PREDICTIVE VALUE; PPV; PRESCRIPTION; PSA; PSORIATIC ARTHRITIS; RA; RAMQ; RECEIVER OPERATING CHARACTERISTIC (CURVE AREA); REGIE DE L'ASSURANCE MALADIE DU QUEBEC; RF; RHEUMATOID ARTHRITIS; RHEUMATOID FACTOR; ROC; RX; SLE; SYSTEMIC LUPUS ERYTHEMATOSUS; THR; TOTAL HIP REPLACEMENT; VA; VALIDATION; VAMC; VETERANS AFFAIRS MEDICAL CENTER; VETERANS AFFAIRS/ADMINISTRATION; VETERANS INTEGRATED SERVICES NETWORK; VISN;

ALGORITHMS; ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; INTERNATIONAL CLASSIFICATION OF DISEASES;

EID: 84892143239     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.075     Document Type: Review

References (118)

1. Nguyen M., Ball R., Midthun K., Lieu T.A. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Saf 2012, 21(January (Suppl. 1)):291-297.
2. Lieu T.A., Nguyen M.D., Ball R., Martin D.B. Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program. Vaccine 2012, 30(April (18)):2824-2830.
3. Vial T., Descotes J. Autoimmune diseases and vaccinations. Eur J Dermatol 2004, 14(March-April (2)):86-90.
4. Pope J.E., Stevens A., Howson W., Bell D.A. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998, 25(September (9)):1687-1693.
5. Sturkenboom M., Fautrel B., Rozenberg S., Begaud B., Roullett E., Heinzlef O. Vaccinations against Hepatitis B and Lupus Erythematosus. Pharmacoepidemiol Drug Saf 2000, 9(S1):71.
6. Sturkenboom M., Fautrel B., Rozenberg S., Begaud B., Roullett E., Heinzlef O. Vaccinations against Hepatitis B and rheumatoid arthritis. Pharmacoepidemiol Drug Saf 2000, 9(S1):71.
7. Ray P., Black S., Shinefield H., Dillon A., Carpenter D., Lewis E., et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine 2011, 29(September (38)):6592-6597.
8. Spector T.D. Rheumatoid arthritis. Rheum Dis Clin North Am 1990, 16(August (3)):513-537.
9. Doran M.F., Crowson C.S., Pond G.R., O'Fallon W.M., Gabriel S.E. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002, 46(September (9)):2287-2293.
10. Singh J.A., Furst D.E., Bharat A., Curtis J.R., Kavanaugh A.F., Kremer J.M., et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012, 64(May (5)):625-639.
11. McPheeters M, Sathe N, Jerome R, Carnahan R. Methods for Systematic Reviews of Administrative Database Studies Capturing Health Outcomes of Interest Vaccine (in review).
12. Carnahan R.M., Moores K.G. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012, 21(January (Suppl. 1)):82-89.
13. Ng B., Aslam F., Petersen N.J., Yu H.J., Suarez-Almazor M.E. Identification of rheumatoid arthritis patients using an administrative database: a veterans affairs study. Arthritis Care Res (Hoboken) 2012, 64(October (10)):1490-1496.
14. Singh J.A., Holmgren A.R., Noorbaloochi S. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum 2004, 51(December (6)):952-957.
15. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(March (3)):315-324.
16. Katz J.N., Barrett J., Liang M.H., Bacon A.M., Kaplan H., Kieval R.I., et al. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum 1997, 40(September (9)):1594-1600.
17. Liao K.P., Cai T., Gainer V., Goryachev S., Zeng-treitler Q., Raychaudhuri S., et al. Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010, 62(August (8)):1120-1127.
18. Kim S.Y., Servi A., Polinski J.M., Mogun H., Weinblatt M.E., Katz J.N., et al. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 2011, 13(February (1)):R32.
19. Losina E., Barrett J., Baron J.A., Katz J.N. Accuracy of medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003, 56(June (6)):515-519.
20. Klein N.P., Ray P., Carpenter D., Hansen J., Lewis E., Fireman B., et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010, 28(January (4)):1062-1068.
21. Bili A., Sartorius J.A., Kirchner H.L., Morris S.J., Ledwich L.J., Antohe J.L., et al. Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients. J Clin Rheumatol 2011, 17(April (3)):115-120.
22. MacLean C.H., Traina S.B., Liu H., Hahn B., Paulus H., kahn K.L. Positive predicitive value of an administrative data-based algorithm for the identification of patients with rheumatoid arthritis (RA). Arthritis Rheum 2001, 44(S9):324.
23. Carroll R.J., Thompson W.K., Eyler A.E., Mandelin A.M., Cai T., Zink R.M., et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc 2012, 19(June (e1)):e162-e169.
24. O'Malley K.J., Cook K.F., Price M.D., Wildes K.R., Hurdle J.F., Ashton C.M. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005, 40(October (5 Pt 2)):1620-1639.
25. Scott D.L., Wolfe F., Huizinga T.W. Rheumatoid arthritis. Lancet 2010, 376(September (9746)):1094-1108.
26. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62(September 9):2569-2581.
27. Humphreys J.H., Verstappen S.M., Hyrich K.L., Chipping J.R., Marshall T., Symmons D.P. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria, Results from the Norfolk Arthritis Register. Ann Rheum Dis 2012, (September).
28. Rowbotham E.L., Grainger A.J. Rheumatoid arthritis: ultrasound versus MRI. AJR Am J Roentgenol 2011, 197(September 3):541-546.
29. Beukelman T., Haynes K., Curtis J.R., Xie F., Chen L., Bemrich-Stolz C.J., et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 2012, 64(April (4)):1263-1271.
30. Blumentals W.A., Arreglado A., Napalkov P., Toovey S. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskelet Disord 2012, 13(August (1)):158.
31. Chu L.H., Portugal C., Kawatkar A.A., Stohl W., Nichol M.B. Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California medicaid rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2013, 65(February (2)):299-303.
32. De Vera M.A., Choi H., Abrahamowicz M., Kopec J., Lacaille D. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 2012, 64(June (6)):809-816.
33. Jain A., Stein B.E., Skolasky R.L., Jones L.C., Hungerford M.W. Total joint arthroplasty in patients with rheumatoid arthritis: a United States experience from 1992 through 2005. J Arthroplasty 2012, 27(June (6)):881-888.
34. Kim S.C., Schneeweiss S., Myers J.A., Liu J., Solomon D.H. No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population. Arthritis Rheum 2012, 64(October 10):3076-3082.
35. Kim S.Y., Schneeweiss S., Liu J., Solomon D.H. Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study. J Bone Miner Res 2012, 27(April (4)):789-796.
36. Rogers M.A., Levine D.A., Blumberg N., Fisher G.G., Kabeto M., Langa K.M. Antigenic challenge in the etiology of autoimmune disease in women. J Autoimmun 2012, 38(May (2-3)):J97-J102.
37. Widdifield J., Bernatsky S., Paterson J.M., Gunraj N., Thorne J.C., Pope J., Cividino A., Bombardier C. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2013, 65(March (3)):353-361.
38. Amari W., Zeringue A.L., McDonald J.R., Caplan L., Eisen S.A., Ranganathan P. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis. Rheumatology (Oxford) 2011, 50(August (8)):1431-1439.
39. Bili A., Schroeder L.L., Ledwich L.J., Kirchner H.L., Newman E.D., Wasko M.C. Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population. Rheumatol Int 2011, 31(September (9)):1159-1165.
40. Curtis J., Chen S.Y., Werther W., John A., Johnson D. Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients. Pharmacoepidemiol Drug Saf 2011, 20(11):1150-1158.
41. Curtis J.R., Xie F., Chen L., Spettell C., McMahan R.M., Fernandes J., et al. The incidence of gastrointestinal perforations among rheumatoid arthritis patients. Arthritis Rheum 2011, 63(February (2)):346-351.
42. Curtis J.R., Xie F., Chen L., Baddley J.W., Beukelman T., Saag K.G., et al. The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Ann Rheum Dis 2011, 70(August (8)):1401-1406.
43. De Vera M.A., Choi H., Abrahamowicz M., Kopec J., Goycochea-Robles M.V., Lacaille D. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 2011, 70(June (6)):1020-1024.
44. Lacaille D., Anis A.H., Guh D.P., Esdaile J.M. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005, 53(April (2)):241-248.
45. Dixon W.G., Kezouh A., Bernatsky S., Suissa S. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann Rheum Dis 2011, 70(June (6)):956-960.
46. Farng E., Zingmond D., Krenek L., Soohoo N.F. Factors predicting complication rates after primary shoulder arthroplasty. J Shoulder Elbow Surg 2011, 20(June (4)):557-563.
47. Kuriya B., Hernández-Díaz S., Liu J., Bermas B.L., Daniel G., Solomon D.H. Patterns of medication use during pregnancy in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011, 63(May (5)):721-728.
48. Lane M.A., McDonald J.R., Zeringue A.L., Caplan L., Curtis J.R., Ranganathan P., et al. TNF-alpha antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis. Medicine (Baltimore) 2011, 90(March (2)):139-145.
49. Louder A.M., Joshi A.V., Ball A.T., Cappelleri J.C. Impact of Celecoxib restrictions in medicare beneficiaries with arthritis. Am J Manag Care 2011, 17(7):503-512.
50. McBride S., Sarsour K., White L.A., Nelson D.R., Chawla A.J., Johnston J.A. Biologic disease-modifying drug treatment patterns and associated costs for patients with rheumatoid arthritis. J Rheumatol 2011, 38(October (10)):2141-2149.
51. Solomon D.H., Massarotti E., Garg R., Liu J., Canning C., Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 2011, 305(June (24)):2525-2531.
52. Winthrop K.L., Baxter R., Liu L., McFarland B., Austin D., Varley C., et al. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf 2011, 20(March (3)):229-235.
53. Bartels C.M., Bell C.L., Shinki K., Rosenthal A., Bridges A.J. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford) 2010, 49(September (9)):1670-1675.
54. Ferucci E.D., Donnithorne K.J., Koller K.R., Swango-Wilson A., Pflaum J., Lanier A.P. Performance on rheumatoid arthritis quality indicators in an Alaska Native healthcare system. Qual Saf Health Care 2010, 19(October (5)):387-391.
55. Kim S.Y., Schneeweiss S., Liu J., Daniel G.W., Chang C.L., Garneau K., et al. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 2010, 12(4):R154.
56. Petri H., Maldonato D., Robinson N.J. Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database. BMC Musculoskelet Disord 2010, 11:247.
57. Solomon D.H., Rassen J.A., Glynn R.J., Lee J., Levin R., Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010, 170(December (22)):1968-1976.
58. Solomon D.H., Love T.J., Canning C., Schneeweiss S. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010, 69(December (12)):2114-2117.
59. Bartels C., Bell C., Rosenthal A., Shinki K., Bridges A. Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study. Arthritis Rheum 2009, 60(September (9)):2553-2557.
60. Brassard P., Lowe A.M., Bernatsky S., Kezouh A., Suissa S. Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum 2009, 61(March (3)):300-304.
61. Cook C., Hawkins R., Aldridge J.M., Tolan S., Krupp R., Bolognesi M. Comparison of perioperative complications in patients with and without rheumatoid arthritis who receive total elbow replacement. J Shoulder Elbow Surg 2009, 18(January-February (1)):21-26.
62. Gadalla S.M., Amr S., Langenberg P., Baumgarten M., Davidson W.F., Schairer C., et al. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. Br J Cancer 2009, 100(March (5)):817-821.
63. Liang K.P., Kremers H.M., Crowson C.S., Snyder M.R., Therneau T.M., Roger V.L., et al. Autoantibodies and the risk of cardiovascular events. J Rheumatol 2009, 36(November (11)):2462-2469.
64. Matta F., Singala R., Yaekoub A.Y., Najjar R., Stein P.D. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009, 101(January (1)):134-138.
65. McDonald J.R., Zeringue A.L., Caplan L., Ranganathan P., Xian H., Burroughs T.E., et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009, 48(May (10)):1364-1371.
66. Molloy E.S., Calabrese L.H. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 2009, 60(December (12)):3761-3765.
67. Parikh-Patel A., White R.H., Allen M., Cress R. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control 2009, 20(August (6)):1001-1010.
68. Patkar N.M., Curtis J.R., Teng G.G., Allison J.J., Saag M., Martin C., et al. Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients. J Clin Epidemiol 2009, 62(March (3)):321-327. 7e1-7.
69. Scherrer J.F., Virgo K.S., Zeringue A., Bucholz K.K., Jacob T., Johnson R.G., et al. Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis. Gen Hosp Psychiatry 2009, 31(July-August (4)):353-359.
70. Silverman S., Dukes E.M., Johnston S.S., Brandenburg N.A., Sadosky A., Huse D.M. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin 2009, 25(April (4)):829-840.
71. Barnabe C., Elias B., Bartlett J., Roos L., Peschken C. Arthritis in Aboriginal Manitobans: evidence for a high burden of disease. J Rheumatol 2008, 35(June (6)):1145-1150.
72. Bernatsky S., Clarke A., Suissa S. Lung cancer after exposure to disease modifying anti-rheumatic drugs. Lung Cancer 2008, 59(February (2)):266-269.
73. Cohen R., Robinson D., Paramore C., Fraeman K., Renahan K., Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis 2008, 14(June (6)):738-743.
74. Ehrmann Feldman D., Bernatsky S., Abrahamowicz M., Roy Y., Xiao Y., Haggerty J., et al. Consultation with an arthritis specialist for children with suspected juvenile rheumatoid arthritis: a population-based study. Arch Pediatr Adolesc Med 2008, 162(June (6)):538-543.
75. Grijalva C.G., Chung C.P., Stein C.M., Gideon P.S., Dyer S.M., Mitchel E.F., et al. Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis. Pharmacoepidemiol Drug Saf 2008, 17(September (9)):890-895.
76. Grijalva C.G., Chung C.P., Stein C.M., Mitchel E.F., Griffin M.R. Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology (Oxford) 2008, 47(July (7)):1061-1064.
77. Han C., Zhao N., Rahman M.U., Doyle M.K., Bala M.V. A case-control study of anaemia in patients with rheumatoid arthritis treated with disease-modifying antirheumatic drugs in an adult population in the US: prevalence and impact on healthcare utilisation. J Med Econ 2008, 11(2):255-264.
78. Hochberg M.C., Johnston S.S., John A.K. The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. Curr Med Res Opin 2008, 24(February (2)):469-480.
79. Janicke D.M., Harman J.S., Kelleher K.J., Zhang J. Psychiatric diagnosis in children and adolescents with obesity-related health conditions. J Dev Behav Pediatr 2008, 29(August (4)):276-284.
80. Khurana R., Wolf R., Berney S., Caldito G., Hayat S., Berney S.M. Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans. J Rheumatol 2008, 35(September (9)):1704-1708.
81. Lacaille D., Guh D.P., Abrahamowicz M., Anis A.H., Esdaile J.M. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum 2008, 59(August (8)):1074-1081.
82. Smitten A.L., Choi H.K., Hochberg M.C., Suissa S., Simon T.A., Testa M.A., et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 2008, 35(March (3)):387-393.
83. Ting G., Schneeweiss S., Scranton R., Katz J.N., Weinblatt M.E., Young M., et al. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther 2008, 10(4):R95.
84. Ting G., Schneeweiss S., Katz J.N., Weinblatt M.E., Cabral D., Scranton R.E., et al. Performance of a rheumatoid arthritis records-based index of severity. J Rheumatol 2005, 32(September (9)):1679-1687.
85. Bernatsky S., Hudson M., Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 2007, 46(July (7)):1157-1160.
86. Curtis J.R., Xi J., Patkar N., Xie A., Saag K.G., Martin C. Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007, 56(December (12)):4226-4227.
87. Curtis J.R., Patkar N., Xie A., Martin C., Allison J.J., Saag M., et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007, 56(April (4)):1125-1133.
88. Curtis J.R., Kramer J.M., Martin C., Saag K.G., Patkar N., Shatin D., et al. Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists. Rheumatology (Oxford) 2007, 46(November (11)):1688-1693.
89. Curtis J.R., Martin C., Saag K.G., Patkar N.M., Kramer J., Shatin D., et al. Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Arthritis Rheum 2007, 57(March (2)):343-346.
90. Khanna R., Smith M.J. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis. Clin Ther 2007, 29(November (11)):2456-2467.
91. Lee T.A., Pickard A.S., Bartle B., Weiss K.B. Osteoarthritis: a comorbid marker for longer life?. Ann Epidemiol 2007, 17(May (5)):380-384.
92. Sacks J.J., Helmick C.G., Luo Y.H., Ilowite N.T., Bowyer S. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. Arthritis Rheum 2007, 57(December (8)):1439-1445.
93. Smitten A.L., Choi H.K., Hochberg M.C., Suissa S., Simon T.A., Testa M.A., et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007, 57(December (8)):1431-1438.
94. Weng X., Liu L., Barcellos L.F., Allison J.E., Herrinton L.J. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol 2007, 102(July (7)):1429-1435.
95. Brassard P., Kezouh A., Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 2006, 43(September (6)):717-722.
96. Canales B.K., Leonard S.M., Singh J.A., Orzano I.M., Zimmermann B., Weiland D., et al. Spondyloarthropathy: an independent risk factor for kidney stones. J Endourol 2006, 20(August (8)):542-546.
97. Han C., Robinson D.W., Hackett M.V., Paramore L.C., Fraeman K.H., Bala M.V. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006, 33(November (11)):2167-2172.
98. Reed S.D., Vollan T.A., Svec M.A. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 2006, 10(July (4)):361-366.
99. Robinson D., Hackett M., Wong J., Kimball A.B., Cohen R., Bala M. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002. Curr Med Res Opin 2006, 22(May (5)):989-1000.
100. Seeger J.D., West W.A., Fife D., Noel G.J., Johnson L.N., Walker A.M. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf 2006, 15(November (11)):784-792.
101. Solomon D.H., Katz J.N., Cabral D., Patrick A.R., Bukowski J.F., Coblyn J.S. Osteoporosis management in patients with rheumatoid arthritis: evidence for improvement. Arthritis Rheum 2006, 55(December (6)):873-877.
102. Solomon D.H., Goodson N.J., Katz J.N., Weinblatt M.E., Avorn J., Setoguchi S., et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006, 65(December (12)):1608-1612.
103. Suissa S., Bernatsky S., Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 2006, 55(August (4)):531-536.
104. Suissa S., Hudson M., Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum 2006, 54(May (5)):1435-1439.
105. Weir P.T., Harlan G.A., Nkoy F.L., Jones S.S., Hegmann K.T., Gren L.H., et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006, 12(June (3)):124-128.
106. Bernatsky S., Hudson M., Suissa S. Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis. Rheumatology (Oxford) 2005, 44(May (5)):677-680.
107. Suissa S., Ernst P., Hudson M., Bitton A., Kezouh A. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. Am J Med 2004, 117(2):87-92.
108. Mauldin J., Cameron H.D., Jeanotte D., Solomon G., Jarvis J.N. Chronic arthritis in children and adolescents in two Indian health service user populations. BMC Musculoskelet Disord 2004, August (5):30.
109. Nissenson A.R., Wade S., Goodnough T., Knight K., Dubois R.W. Economic burden of anemia in an insured population. J Manag Care Pharm 2005, 11(September (7)):565-574.
110. Briesacher B., Kamal-Bahl S., Hochberg M., Orwig D., Kahler K.H. Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs. Arch Intern Med 2004, 164(August (15)):1679-1684.
111. Ward M.M. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum 2004, 50(April (4)):1122-1131.
112. Alderman A.K., Chung K.C., Demonner S., Spilson S.V., Hayward R.A. The rheumatoid hand: a predictable disease with unpredictable surgical practice patterns. Arthritis Rheum 2002, 47(October (5)):537-542.
113. Hootman J.M., Helmick C.G., Schappert S.M. Magnitude and characteristics of arthritis and other rheumatic conditions on ambulatory medical care visits, United States, 1997. Arthritis Rheum 2002, 47(December (6)):571-581.
114. Griffiths R.I., Bar-Din M., MacLean C., Sullivan E.M., Herbert R.J., Yelin E.H. Patterns of disease-modifying antirheumatic drug use, medical resource consumption, and cost among rheumatoid arthritis patients. Ther Apher 2001, 5(April (2)):92-104.
115. MacLean C.H., Louie R., Leake B., McCaffrey D.F., Paulus H.E., Brook R.H., et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000, 284(August (8)):984-992.
116. Walsh S.J., Rau L.M. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000, 90(September (9)):1463-1466.
117. Rosenman K.D., Zhu Z. Pneumoconiosis and associated medical conditions. Am J Ind Med 1995, 27(January (1)):107-113.
118. Gridley G., Klippel J.H., Hoover R.N., Fraumeni J.F. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994, 120(January (1)):35-39.